Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -57,270 | -44,783 | -30,857 | -16,211 |
| Depreciation Amortization | 3,650 | 2,828 | 1,921 | 923 |
| Accounts payable and accrued liabilities | -729 | -1,584 | -1,523 | -743 |
| Other Working Capital | -4,160 | -3,599 | -3,483 | -1,886 |
| Other Operating Activity | 5,529 | 5,169 | 3,850 | 1,767 |
| Operating Cash Flow | $-52,980 | $-41,969 | $-30,092 | $-16,150 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 25,154 | 21,375 | 38,289 | 20,727 |
| PPE Investments | -1,580 | -894 | -642 | -468 |
| Other Investing Activity | -4 | 0 | 0 | 0 |
| Investing Cash Flow | $23,570 | $20,481 | $37,647 | $20,259 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -2,086 | -1,528 | -990 | -466 |
| Common Stock Issued | 2 | 2 | 2 | N/A |
| Other Financing Activity | 41,364 | 41,007 | 40,847 | 754 |
| Financing Cash Flow | $39,280 | $39,481 | $39,859 | $288 |
| Beginning Cash Position | 23,800 | 23,809 | 23,809 | 23,809 |
| End Cash Position | 33,680 | 41,802 | 71,223 | 28,206 |
| Net Cash Flow | $9,870 | $17,993 | $47,414 | $4,397 |
| Free Cash Flow | ||||
| Operating Cash Flow | -52,980 | -41,969 | -30,092 | -16,150 |
| Capital Expenditure | -1,580 | -894 | -642 | -468 |
| Free Cash Flow | -54,560 | -42,863 | -30,734 | -16,618 |